Navigation Links
Medela Announces Virtual Breast Milk Collection Campaign in Honor of Prematurity Awareness Month
Date:11/1/2012

McHenry, Ill., Nov. 1, 2012 /PRNewswire/ -- Human milk acts as a medicine for premature babies who are vulnerable to potentially fatal diseases such as necrotizing enterocolitis, an intestinal disease. To help demonstrate the importance of breastmilk and the NICU staff's role in facilitating access to it, and in honor of the  March of Dimes' National Prematurity Awareness Month Medela, Inc., will host its fourth annual Human Milk (breast milk) Collection Campaign. As part of the campaign, Medela will donate a total of $30,000 in breastfeeding support products to neonatal intensive care units across the country.

According to the American Academy of Pediatrics, UNICEF, and the U.S. Surgeon General, breast milk provides the optimal nutrition for babies.i,ii,iii  In the United States, the rate of premature births has been increasing, and this year more than 517,000 babies will be born premature.

"Breast milk for premature babies is critical, but breastfeeding in the NICU presents special challenges," says Carolin Archibald, president, Medela Inc.  "We're thrilled to be able to support National Prematurity Awareness Month by donating products to several NICUs.  The winning NICUs will be equipped with products to help mothers develop and maintain their breastmilk supply while their babies benefit from their milk."

Feeding human milk rather than formula in the NICU has been shown to reduce the length of hospital stay, days of oxygen therapy needed, and incidence of late-onset sepsis, necrotizing enterocolitis (NEC), ear infections, serious respiratory tract infections and gastroenteritis.

How the Campaign Works: 
Throughout the month of November, participants can visit www.medelapreemieawareness.com to vote for their preferred Neonatal Intensive Care Unit (NICU). One NICU from each of six geographic regions will receive $5,000 worth of Medela products for their facility, including Symphony® Preemie+™ program cards, Symphony breastpumps, Waterless Milk Warmers™, Transport/Discharge Bags, BabyWeigh II™ scales. Voting is open to the general public and NICUs are encouraged to campaign for votes. Each person may vote only once and voting begins November 1 and continues through November 30.  For full details on the promotion, please visit www.medelapreemieawareness.com.

About Medela:   
Medela provides the most technologically advanced breastpumps and breastfeeding accessories to nursing mothers around the world. A long-time champion of breastfeeding, Medela is the only company to develop products based on research by the world's leading lactation experts. As a result, Medela's breastpumps are the number one choice of healthcare professionals and facilities worldwide.

Medela has developed an extensive line of products to meet the diverse needs of nursing mothers.  These products include hospital-grade, double and single electric and manual personal breastpumps; breastfeeding accessories such as breast care products and specialty feeding devices. Most recently, Medela introduced 2-Phase Expression®, the only research-based breastpump technology that mimics a baby's nursing rhythm, resulting in faster let-down and milk flow.

Founded in 1961 by Olle Larsson in Zug, Switzerland, Medela continues to grow under the ownership of the Larsson family. Medela serves customers through a worldwide network of distribution partners in more than 90 countries and its 15 subsidiaries in Australia, the Benelux countries, Canada, China, France, Germany, Italy, Japan, Russia, the United Kingdom, the United States, Spain, Sweden, Poland and Switzerland. www.medela.com

[i] American Academy of Pediatrics. Accessed August 7, 2012. http://www2.aap.org/breastfeeding/policyOnBreastfeedingAndUseOfHumanMilk.html

[ii] UNICEF. Accessed August 7, 2012. http://www.unicef.org/nutrition/index_24824.html.

[iii] U.S. Department of Health and Human Services. Accessed August 7, 2012. http://www.womenshealth.gov/breastfeeding/.

Media Contact: 
Claudette Yasell 
815-578-2452 
Claudette.yasell@medela.com  


'/>"/>
SOURCE Medela
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
2. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
3. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
4. Watson Announces Global Generics Management Team
5. Watson Announces New Name -- Actavis -- for Global Operations
6. BioMed Realty Announces 93,000 Square Foot Lease Expansion And Extension With Ironwood Pharmaceuticals At 301 Binney Street
7. Abaxis Announces Exclusive Distribution Agreement with Abbott
8. Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds
9. Lilly Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice President; Announces Retirement of Anne Nobles
10. Neuraltus Pharmaceuticals Announces Phase 2 Clinical Results for NP001 in Patients with Amyotrophic Lateral Sclerosis (ALS)
11. Jazz Pharmaceuticals Announces Date to Release Third Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... YORK , Jan. 19, 2017 ... USD 233.7 billion by 2025, according to a ... market is anticipated to be predominantly driven by ... resulting into the large-scale production of new and ... the influx of drugs at an unprecedented rate ...
(Date:1/19/2017)... 19, 2017 Conference Call and Webcast to Follow ... announced it will release results for the fourth quarter of 2016 ... ... conference call at 4:30 PM ET on Wednesday, February 15, 2017, ... 2016 financial results and other corporate activities. To participate in the ...
(Date:1/19/2017)... , Jan. 19, 2017  Stealth BioTherapeutics Inc. ... to treat mitochondrial dysfunction, today announced new additions to ... M.D., as Chief Medical Officer, and Daniel Geffken ... announced that Jim Carr , Pharm.D. has been ... "We are pleased to welcome Doug and Daniel to ...
Breaking Medicine Technology:
(Date:1/20/2017)... York, NY (PRWEB) , ... January 20, 2017 ... ... – VW+ 001 and its sugar-free alternative VW+ 002. The drinks have been ... body with optimal conditions to perform during your workout. , After a successful ...
(Date:1/20/2017)... ... January 20, 2017 , ... D R ... Pressure (OPEP) device, was featured in a study indicating superior performance against competitive ... “Analysis of Three Oscillating Positive Expiratory Pressure Devices During Simulated Breathing“ was ...
(Date:1/20/2017)... ... 2017 , ... “God's Miracle Man: Against All Odds”: an inspiring affirmation ... author, Keith C. A. Tucker, son of Minister Delores Pinnock and a Jamaican native ... Mark Hardy , “While sitting up in bed, I felt a pounding headache. It ...
(Date:1/19/2017)... ... January 19, 2017 , ... With the cold weather here, many people will have to clear ... when clearing large amounts of snow, but they can be dangerous when used incorrectly. That’s ... Safety Commission for the proper use of snow blowers:, , When ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online plastic ... in order to make it easier for their readers to get the information they ... impact as well as the techniques used on those particular areas. , “We are ...
Breaking Medicine News(10 mins):